Related Experiment Video
Updated: Feb 2, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
Clinical study on hemoporfin PDT for infant facial port-wine stains
Yunjie Zhang1, Yuguang Yang1, Zhe Zhang1
1Department of Dermatology of First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Insights
Hemoporfin photodynamic therapy (PDT) effectively treats infant facial port-wine stains (PWS), showing a 98% efficacy rate. Adverse reactions were minimal, indicating a safe and beneficial therapeutic option.
Area of Science:
- Dermatology
- Photomedicine
- Pediatric Medicine
Background:
- Infant facial port-wine stains (PWS) present a significant cosmetic and psychological concern.
- Photodynamic therapy (PDT) offers a potential treatment modality for vascular lesions.
Purpose of the Study:
- To evaluate the clinical efficacy and therapeutic response of Hemoporfin photodynamic therapy (PDT) for infant facial port-wine stains (PWS).
Main Methods:
- 100 infant cases with facial PWS were treated using Hemoporfin PDT.
- Treatment involved intravenous Hemippofen injection followed by irradiation with 532 nm LED green light.
- Therapeutic response and clinical efficacy were monitored via a digital consulting platform.
Main Results:
- An overall effective rate of 98% was achieved.
- Common transient side effects included itching (85%), edema (100%), purpura-like changes (89%), and crusting (33%).
- Minimal long-term adverse effects were observed, with hyperpigmentation and scarring in 2% of cases, and no systemic reactions.
Conclusions:
- Hemoporfin PDT demonstrates high clinical efficacy and a favorable response rate for treating infant facial PWS.
- The treatment is associated with generally mild and transient adverse reactions, making it a viable option for this pediatric population.
Objective:
To observe the clinical efficacy and therapeutic response of Hemoporfin photodynamic therapy (PDT) for infant facial port-wine stains (PWS).
Method:
Hemoporfin PDT was used to treat 100 cases of infant facial PWS. After receiving Hemoporfin skin test, the cases with a negative skin test result were intravenously injected with Hemippofen (5 mg/kg) and irradiated under 532 nm LED green light. After treatment, a follow-up visit was paid through WeChat and Dermlink PWS consulting platform, in order to observe the therapeutic response and clinical efficacy.
Result:
The follow-up visit showed an effective rate of 98%, including 85 cases of itching (85%), 100 cases of edema (100%), 89 cases of purpura-like change (89%), 33 cases of crust (33%), 2 cases of hyperpigmentation (2%) and 2 cases of scars (2%), with no allergy and other systematic adverse reaction.
Conclusion:
Hemoporfin PDT has a high clinical efficacy and response rate in treating infant facial PWS, with slight adverse reactions.
Related Concept Videos
Muscles for Facial Expressions
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Facial Feedback Hypothesis
Hypertension III: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Drug Dosing: Infants and Children

